standard management clinical trials

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

This study is looking at tailoring colon cancer treatment based on a blood test that measures cancer DNA. It compares this personalised approach to standard treatment to see if it improves how long people live while maintaining a good quality of life.